Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2016 1
2017 1
2018 1
2020 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic and Treatment Strategies for COVID-19.
Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din FU. Jamshaid H, et al. AAPS PharmSciTech. 2020 Aug 3;21(6):222. doi: 10.1208/s12249-020-01756-3. AAPS PharmSciTech. 2020. PMID: 32748244 Free PMC article. Review.
Trial of Chloroquines in the Treatment of COVID-19 and Its Research Progress in Forensic Toxicology.
Duan YJ, Liu Q, Zhao SQ, Huang F, Ren L, Liu L, Zhou YW. Duan YJ, et al. Fa Yi Xue Za Zhi. 2020 Apr;36(2):157-163. doi: 10.12116/j.issn.1004-5619.2020.02.002. Epub 2020 Mar 25. Fa Yi Xue Za Zhi. 2020. PMID: 32212512 Free article. Review. Chinese, English.
The antimalarial drug chloroquine phosphate which has already been approved is confirmed to have an anti-2019-nCoV effect and has been included in diagnostic and therapeutic guidelines. However, awareness of the risk of chloroquine phosphate causing acute poisoning or even …
The antimalarial drug chloroquine phosphate which has already been approved is confirmed to have an anti-2019-nCoV effect and has been inclu …
[An examination of the Cunzhen Huan Zhong Tu].
Miyakawa K. Miyakawa K. Nihon Ishigaku Zasshi. 1996 Mar;42(1):77-86. Nihon Ishigaku Zasshi. 1996. PMID: 11618879 Japanese.
The author has re-examined these on the basis of materials (preserved in Japan) left by the 16th century figure Gen'un. 1. The material used by Gen'un was the Cun Zhen Huanzhong Tu, and he did not cite directly from the Ou Xi-fang Wu Zang Tu. 2. The drawing o …
The author has re-examined these on the basis of materials (preserved in Japan) left by the 16th century figure Gen'un. 1. The material used …
MicroRNA-130b transcriptionally regulated by histone H3 deacetylation renders Akt ubiquitination and apoptosis resistance to 6-OHDA.
Xu L, Jia Y, Yang XH, Han F, Zheng Y, Ni Y, Chen X, Hong J, Liu JQ, Li Q, Sun RH, Mo SJ. Xu L, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1678-1689. doi: 10.1016/j.bbadis.2017.04.012. Epub 2017 Apr 13. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28412322 Free article.
Apoptosis of DA neurons is a contributing cause of disability and death for Parkinson's disease (PD). Akt may become a potential therapeutic target for PD since Akt has been deactivated during DA neuron apoptosis. ...
Apoptosis of DA neurons is a contributing cause of disability and death for Parkinson's disease (PD). Akt may become a potential therapeu
Elevated TRPV2 expression in the facial nerve of rats by cold stimulation: Implications for Bell's palsy.
Zeng Z, Bai Y, Hao W, Zhang T, Yang J, Wu F, Li X. Zeng Z, et al. J Stomatol Oral Maxillofac Surg. 2024 Apr 27:101895. doi: 10.1016/j.jormas.2024.101895. Online ahead of print. J Stomatol Oral Maxillofac Surg. 2024. PMID: 38685355
Moreover, this finding implies that TRPV2 could possibly function as an additional diagnostic marker or therapeutic target in the context of Bell's palsy....
Moreover, this finding implies that TRPV2 could possibly function as an additional diagnostic marker or therapeutic target in the con …
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.
Wei L, Xie Q, Hou JL, Tang H, Ning Q, Cheng J, Nan Y, Zhang L, Li J, Jiang J, McNabb B, Zhang F, Camus G, Mo H, Osinusi A, Brainard DM, Gong G, Mou Z, Wu S, Wang G, Hu P, Gao Y, Jia J, Duan Z. Wei L, et al. Hepatol Int. 2018 Mar;12(2):126-132. doi: 10.1007/s12072-018-9856-z. Epub 2018 Apr 10. Hepatol Int. 2018. PMID: 29637511 Free PMC article. Clinical Trial.